首页> 外文OA文献 >Cross-Protection against a Human Enteric Coronavirus and a Virulent Bovine Enteric Coronavirus in Gnotobiotic Calves▿
【2h】

Cross-Protection against a Human Enteric Coronavirus and a Virulent Bovine Enteric Coronavirus in Gnotobiotic Calves▿

机译:对人肠小牛冠状病毒和牛牛冠状病毒的交叉保护作用▿

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

A group 2 human coronavirus designated HECV-4408 was isolated from a child with acute diarrhea and is antigenically and genetically more closely related to bovine coronavirus (BCoV) than to human coronavirus OC43 (X. M. Zhang, W. Herbst, K. G. Kousoulas, and J. Storz, J. Med. Virol. 44:152-161, 1994). To determine whether HECV-4408 infects gnotobiotic calves and induces cross-protective immunity against the virulent enteric BCoV DB2 strain, gnotobiotic calves (n = 4) were orally inoculated with HECV-4408 and then challenged with BCoV DB2 at postinoculation day (PID) 21. All calves inoculated with HECV-4408 developed diarrhea at PID 3 to 4 lasting 5 to 9 days. Fecal and nasal virus shedding were first detected by reverse transcription-PCR at PID 3 to 4 and at PID 2 to 4, respectively. After challenge with bovine coronavirus, no diarrhea or virus shedding was detected in calves inoculated with HECV-4408, but a mock-inoculated calf developed diarrhea and fecal and nasal shedding. Fecal immunoglobulin A (IgA) and serum IgG antibodies were first detected at PID 7 and PID 14, respectively. At postchallenge day 7, serum IgG and fecal IgA antibody titers remained the same or increased only twofold compared to prechallenge titers. An additional two gnotobiotic calves were inoculated with HECV-4408 and euthanized at PID 5. Moderate villous atrophy was observed in the small intestines, and viral antigen was detected in villous enterocytes of the small and large intestines by immunohistochemistry. These results support and extend the previous report that HECV-4408 is likely a variant of bovine coronavirus. They confirm its infectivity for calves and complete cross-protection against a bovine coronavirus (DB2 strain) showing 98.2% amino acid identity to HECV-4408 in the S protein.
机译:从患有急性腹泻的儿童中分离出第2组人类冠状病毒,命名为HECV-4408,与牛冠状病毒(BCoV)的抗原和遗传关系比与人类冠状病毒OC43(XM Zhang,W.Herbst,KG Kousoulas和J. Storz,J.Med.Virol.44:152-161,1994)。为了确定HECV-4408是否感染gnotobiotic小牛并诱导针对强力肠溶性BCoV DB2菌株的交叉保护免疫力,将gnotobiotic小牛(n = 4)口服HECV-4408,然后在接种后第21天用BCoV DB2攻击21 。接种HECV-4408的所有犊牛在PID为3到​​4时出现腹泻,持续5到9天。首先通过反转录PCR分别在PID 3至4和PID 2至4检测粪便和鼻部病毒的脱落。用牛冠状病毒攻击后,在接种HECV-4408的牛犊中未检测到腹泻或病毒脱落,但模拟接种的牛犊出现了腹泻以及粪便和鼻涕脱落。首先分别在PID 7和PID 14中检测到粪便免疫球蛋白A(IgA)和血清IgG抗体。攻击后第7天,血清IgG和粪便IgA抗体滴度与攻击前滴度相比保持相同或仅增加了两倍。再用HECV-4408接种另外两只生小牛犊,并在PID 5下安乐死。在小肠中观察到中等的绒毛萎缩,并通过免疫组织化学在小肠和大肠的绒毛肠上皮细胞中检测到病毒抗原。这些结果支持并扩展了先前的报道,即HECV-4408可能是牛冠状病毒的变体。他们证实了它对小牛的感染力,并与牛冠状病毒(DB2株)完全交叉保护,与S蛋白中的HECV-4408氨基酸同源性为98.2%。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号